1. Market Research
  2. > Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile

Summary

Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics laboratory services such as core testing, genomic and esoteric testing. Its services include general and specialty laboratory testing, ambulatory monitoring services, bone marrow and human leukocyte antigen (HLA) testing, clinical trials services, drug testing services, DNA identification services, forensic identity services, insurance health plan services, paternity testing services, patient services, personalized medicine and hospital services. It also offers drug development services through Covance. The company has a network of 39 primary laboratories and more than 1700 patient service centers. It offers its services to managed care organizations, physicians, hospitals, government agencies and biotechnology and pharmaceutical companies across all the 50 states in the US, the District of Columbia, Belgium, Puerto Rico, Japan, China, Singapore, the UK and three Canadian provinces. LabCorp is headquartered in Burlington, North Carolina, the US.

Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2010 to YTD 2016 8
Laboratory Corporation of America Holdings, Medical Equipment Deals By Type, 2010 to YTD 2016 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2010 to YTD 2016 10
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Market, 2010 to YTD 2016 11
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2010 to YTD 2016 12
Laboratory Corporation of America Holdings, Medical Equipment, Deal Details 18
Asset Purchase 18
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 18
Pharma Tech Solutions Acquires Genstrip From Shasta Technologies 20
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 21
Gamma-Dynacare Medical Acquires Medical Labs Division Of Warnex 22
Venture Financing 24
Ativa Medical Raises USD15 Million in Series B Financing 24
Vivify Health Raises Funds in Series B Venture Financing 26
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 28
Flatiron Health Raises US$130 Million In Series B Financing 30
Flatiron Health Raises US$8 Million In Series A Financing 32
Nodality Secures US$15.5 Million In Financing Round 34
CancerGuide Diagnostics Raises Additional US$0.7 Million In Financing Round 36
CancerGuide Secures US$10.5 Million In First Tranche Of Venture Financing 38
Private Equity 40
Shore Capital Invests In ClearPath Diagnostics 40
Partnerships 41
Sequenom enters into an Agreement with University of California 41
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 42
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 43
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 45
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 46
LipoScience Enters Into Licensing Agreement With Cleveland Clinic 47
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 48
Sequenom Enters Into Licensing Agreement With LifeCodexx 49
Merck Enters Into Licensing Agreement With Lab Corporation of America Holdings 50
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 51
Sequenom Enters Into Licensing Agreement With Optherion 52
Sysmex Enters into Co-Development Agreement with LabCorp 53
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 54
Gamma-Dynacare Medical Labs Enters Into Agreement With OSR Medical 55
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 56
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 57
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 58
CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 59
CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 60
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 61
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 62
Emdeon Enters Into Strategic Alliance With LabCorp 63
Duke University Medical Center Enters Into Joint Venture With LabCorp 64
CancerGuide Diagnostics Enters Into An Agreement With Lab Corporation of America 65
Merger 66
instaCare Receives Merger Offer From A NASDAQ Traded Company 66
New England Biolabs Enters Into Licensing Agreement With Sequenom 67
University of Minnesota Signs Licensing Agreement With LabCorp 68
Equity Offering 69
LipoScience Completes IPO For US$52 Million 69
Sequenom Completes Public Offering Of Common Stock For US$62 Million 71
Sequenom Completes Public Offering Of US$96.6 Million 73
SEQUENOM Completes Private Placement Of Common Stock For US$51.6 Million 75
Debt Offering 77
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 77
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 79
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 81
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 83
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 85
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 87
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 89
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 91
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 93
LabCorp Completes An Underwritten Public Offering Of 3.125% Senior Notes Due 2016 For US$325 Million 95
LabCorp Completes An Underwritten Public Offering Of 4.625% Senior Notes Due 2020 For US$600 Million 97
Asset Transactions 99
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 99
Marken Acquires European Kit Building Operation Facility From LabCorp 100
Acquisition 101
LabCorp Acquires ClearPath Diagnostics from Shore Capital Partners 101
LabCorp Acquires Sequenom 102
LabCorp Acquires Covance for USD6.1 Billion 104
LabCorp Acquires Bode Technology from SolutionPoint 107
LabCorp Acquires LipoScience for USD85.3 Million 108
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 110
Gamma-Dynacare Medical Labs Acquires Controlling Interest In Impact Genetics 111
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 112
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 113
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 115
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 116
Pathology Holdings Acquires Central Coast Clinical Labs 119
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme 120
Lab Corporation Acquires DCL Medical Labs From Thompson Street Capital Partners 122
LabCorp Sells Minority Stake In Ontario, Canada Joint Venture 123
LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture 124
Laboratory Corporation of America Holdings - Key Competitors 125
Key Employees 126
Locations And Subsidiaries 127
Head Office 127
Other Locations and Subsidiaries 127
Recent Developments 132
Strategy And Business Planning 132
Jun 01, 2015: Sysmex and LabCorp Announce a Strategic Collaboration for Blood-Based Molecular Testing Services and Products to Support the Development of Precision Medicine in Oncology 132
May 19, 2015: ORIG3N Announces Strategic Collaboration with LabCorp 133
Feb 20, 2015: LabCorp Plans For Cost Savings 134
Financial Announcements 135
Oct 26, 2016: Laboratory Corporation of America Holdings Announces 2016 Third Quarter Results and Updates 2016 Guidance 135
Jul 27, 2016: Laboratory Corporation of America Holdings Announces 2016 Second Quarter Results and Raises 2016 Guidance 138
Apr 25, 2016: Laboratory Corporation of America Holdings Announces 2016 First Quarter Results and Raises 2016 Guidance 141
Feb 18, 2016: Laboratory Corporation of America Holdings Announces 2015 Fourth Quarter and Full Year Results and Provides 2016 Guidance 143
Oct 26, 2015: Laboratory Corporation of America Holdings Announces 2015 Third Quarter Results 146
Jul 28, 2015: Laboratory Corporation of America Holdings Announces Record 2015 Second Quarter Results and Raises 2015 Adjusted EPS Guidance 148
Apr 27, 2015: Laboratory Corporation of America Holdings Announces 2015 First Quarter Results 150
Feb 20, 2015: Laboratory Corporation of America Holdings Announces 2014 Fourth Quarter and Full Year Results and Provides 2015 Guidance 152
Corporate Communications 154
Sep 20, 2016: LabCorp Names Veteran Biopharma Executive John Ratliff CEO of Covance Drug Development 154
Apr 11, 2016: LabCorp Hires Jonathan Zung as Group President of Clinical Development and Commercialization Services for Covance Drug Development 155
Jan 07, 2016: LabCorp Announces New Board Member 156
Jul 28, 2015: LabCorp Announces New Covance Leadership 157
Legal and Regulatory 158
Oct 03, 2016: Oxford Immunotec Announces Favorable Decision from U.S. District Court of Massachusetts in Patent Infringement Litigation 158
Sep 01, 2016: Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation 159
Sep 30, 2015: Bode Cellmark Forensics Enters into Service Agreement in Support of Innovative Programs Dedicated to Processing Sexual Assault Kits Nationwide 160
Other Significant Developments 161
Sep 03, 2015: LabCorp Expands Partnership with Perinatal Quality Foundation to Educate Patients and Healthcare Providers about Noninvasive Prenatal Testing 161
Jul 23, 2015: Covance Opens Fit-for-Purpose Dallas Clinical Research Unit 162
Apr 17, 2015: LabCorp offers eSSENTIAL Accessibility App to Make It Easier for People with Disabilities to Manage Health Care Online 163
Appendix 164
Methodology 164
About GlobalData 164
Contact Us 164
Disclaimer 164

List of Tables
Laboratory Corporation of America Holdings, Medical Equipment, Key Facts, 2015 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2010 to YTD 2016 8
Laboratory Corporation of America Holdings, Medical Equipment Deals By Type, 2010 to YTD 2016 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2010 to YTD 2016 10
Laboratory Corporation of America Holdings, Deals By Market, 2010 to YTD 2016 11
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2010 to YTD 2016 12
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 18
Pharma Tech Solutions Acquires Genstrip From Shasta Technologies 20
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 21
Gamma-Dynacare Medical Acquires Medical Labs Division Of Warnex 22
Ativa Medical Raises USD15 Million in Series B Financing 24
Vivify Health Raises Funds in Series B Venture Financing 26
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 28
Flatiron Health Raises US$130 Million In Series B Financing 30
Flatiron Health Raises US$8 Million In Series A Financing 32
Nodality Secures US$15.5 Million In Financing Round 34
CancerGuide Diagnostics Raises Additional US$0.7 Million In Financing Round 36
CancerGuide Secures US$10.5 Million In First Tranche Of Venture Financing 38
Shore Capital Invests In ClearPath Diagnostics 40
Sequenom enters into an Agreement with University of California 41
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 42
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 43
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 45
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 46
LipoScience Enters Into Licensing Agreement With Cleveland Clinic 47
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 48
Sequenom Enters Into Licensing Agreement With LifeCodexx 49
Merck Enters Into Licensing Agreement With Lab Corporation of America Holdings 50
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 51
Sequenom Enters Into Licensing Agreement With Optherion 52
Sysmex Enters into Co-Development Agreement with LabCorp 53
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 54
Gamma-Dynacare Medical Labs Enters Into Agreement With OSR Medical 55
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 56
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 57
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 58
CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 59
CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 60
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 61
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 62
Emdeon Enters Into Strategic Alliance With LabCorp 63
Duke University Medical Center Enters Into Joint Venture With LabCorp 64
CancerGuide Diagnostics Enters Into An Agreement With Lab Corporation of America 65
instaCare Receives Merger Offer From A NASDAQ Traded Company 66
New England Biolabs Enters Into Licensing Agreement With Sequenom 67
University of Minnesota Signs Licensing Agreement With LabCorp 68
LipoScience Completes IPO For US$52 Million 69
Sequenom Completes Public Offering Of Common Stock For US$62 Million 71
Sequenom Completes Public Offering Of US$96.6 Million 73
SEQUENOM Completes Private Placement Of Common Stock For US$51.6 Million 75
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 77
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 79
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 81
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 83
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 85
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 87
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 89
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 91
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 93
LabCorp Completes An Underwritten Public Offering Of 3.125% Senior Notes Due 2016 For US$325 Million 95
LabCorp Completes An Underwritten Public Offering Of 4.625% Senior Notes Due 2020 For US$600 Million 97
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 99
Marken Acquires European Kit Building Operation Facility From LabCorp 100
LabCorp Acquires ClearPath Diagnostics from Shore Capital Partners 101
LabCorp Acquires Sequenom 102
LabCorp Acquires Covance for USD6.1 Billion 104
LabCorp Acquires Bode Technology from SolutionPoint 107
LabCorp Acquires LipoScience for USD85.3 Million 108
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 110
Gamma-Dynacare Medical Labs Acquires Controlling Interest In Impact Genetics 111
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 112
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 113
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 115
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 116
Pathology Holdings Acquires Central Coast Clinical Labs 119
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme 120
Lab Corporation Acquires DCL Medical Labs From Thompson Street Capital Partners 122
LabCorp Sells Minority Stake In Ontario, Canada Joint Venture 123
LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture 124
Laboratory Corporation of America Holdings, Key Competitors 125
Laboratory Corporation of America Holdings, Key Employees 126
Laboratory Corporation of America Holdings, Other Locations 127
Laboratory Corporation of America Holdings, Subsidiaries 129

List of Figures
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2010 to YTD 2016 8
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Type, 2010 to YTD 2016 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2010 to YTD 2016 10
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Market, 2010 to YTD 2016 11

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.